SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001385508-23-000003
Filing Date
2023-01-04
Accepted
2023-01-04 16:20:38
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFM14A projectrainbow-definitivep.htm DEFM14A 2646073
2 image.jpg GRAPHIC 6031
3 image_0.jpg GRAPHIC 110764
  Complete submission text file 0001385508-23-000003.txt   2808267
Mailing Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 464744124 | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-38193 | Film No.: 23506723
SIC: 2834 Pharmaceutical Preparations